Full‑spectrum non‑dilutive strategy
One page, everything you need. We design and manage the portfolio, keep you compliant post‑award, build internal capability, and align R&D with commercialization.
Non‑Dilutive Funding Portfolio
We pursue 3–5 aligned opportunities in parallel across NSF, NIH, DoD and IRAP/SR&ED. Expect a 90‑day and 12‑month roadmap, reviewer‑first narratives, tight budgets, and a submission calendar that keeps you in motion.
Compliance & Post‑Award Finance
Win it, spend it right, stay audit‑ready. We set up allowability, time & effort, indirects, and reporting rhythms a CFO appreciates. We help you capture TABA where applicable and keep the trail clean for Phase II/III.
Workshops & Grant Readiness
Executive briefings for CEOs/boards and working sprints on SBIR/STTR mechanics, Specific Aims, commercialization narratives, and compliance best practices.
Commercialization & Finance Advisory
Milestone roadmaps, pricing & GTM, partner development, and investor narratives that explicitly connect non‑dilutive wins to valuation.
Ready to build your funding portfolio?
We’ll map your first 90 days and the parallel opportunities that fit.